NCT01798628View on ClinicalTrials.gov

A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

36

Participants

Timeline

Start Date

September 30, 2009

Primary Completion Date

October 31, 2009

Study Completion Date

October 31, 2009

Conditions
Healthy Volunteers
Interventions
DRUG

Treatment A: abiraterone acetate

1000 mg (4 x 250 mg tablets) taken by mouth as a single dose administered after a high-fat meal

DRUG

Treatment B: abiraterone acetate

1000 mg (4 x 250 mg tablets) taken by mouth as a single dose after a low-fat meal

DRUG

Treatment C: abiraterone acetate

1000 mg (4 x 250 mg tablets) taken by mouth as a single dose administered in the fasted state

Sponsors
All Listed Sponsors
lead

Cougar Biotechnology, Inc.

INDUSTRY